Agoracom: Small Cap Investment - Zenith Epigenetics - Keep an eye on Constellation Pharmaceuticals

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Keep an eye on Constellation Pharmaceuticals

posted on Dec 10, 2015 03:50PM

We should all keep an eye on Constellation Pharmaceuticals. They seem to have a head start on Zenith based upon their 3 ongoing Phase 1 cancer trials (all for the same first generation BET inhbibor CPI-0610), but we all know the story of the tortoise and the hare......